Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Cancer Res. 2010 Nov 2;70(22):9207–9217. doi: 10.1158/0008-5472.CAN-10-1743

Fig. 5.

Fig. 5

RecQL4 suppression drastically reduces cell invasiveness in vitro and tumorigenic growth in vivo. (A) RecQL4 suppressed clonal cell lines (C4 and C6) showed reduced cell invasion capacity. (B&C) Suppression of RecQL4 expression in prostate cancer cells reduces tumorigenicity in nude mice. Images of tumors dissected out from the sacrificed mice are shown in B. The tumor size (mm3) versus days of post-injection is shown in C. Difference in relative tumor volume observed at 4 weeks between empty vector and RecQL4 ShRNA transfected cells were found to be statistically significant. *p < 0.01.